ZTS Sınıf A Zoetis Inc. Class A Common Stock
NYSE · Pharmaceuticals · SEC EDGAR'da Görüntüle ↗ kapat Eki 2, 2026 10-K/10-Q Ağu 6, 2026
$69,69
· 52 haftalık aralığın %'i
· düşüğün üstünde
· yükseğe
$68,7852 haftanın en düşüğü
$148,3052 haftanın en yükseği
Piyasa Değeri (MRQ)
$28.86B
P/E (TTM)
11.5
Hisse Başına Kâr (TTM)
$6.07
Gelir (TTM)
$9.52B
rozetleriniz
52 Haftlık Aralık
$69–$148
Analist Derecelendirmesi
HOLD
Fiyat Hedefi
$96
P/E
11.5
ROE
64.4%
Net Kâr Marjı
27.5%
Rozet şeridiniz boş — bu sayfada herhangi bir metriği sabitleyin.
ZTS Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$69.69
Piyasa Değeri (MRQ)
$28.86B
P/E (TTM)
11.5
Hisse Başına Kâr (TTM)
$6.07
Gelir (TTM)
$9.52B
ROE (TTM)
64.4%
D/E Borç/Özsermaye (MRQ)
2.9
52 Haftlık Aralık
$69–$148
ZTS Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
aralık
çubuklar
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
Zoetis Inc. Class A Common Stock Hakkında Wikipedia'dan şirket genel bakışı
Zoetis Inc. (/zō-EH-tis/), headquartered in Parsippany, New Jersey, is the largest producer of medicine and vaccinations for pets and livestock worldwide. The company's products include antiparasitics, vaccines, products that relieve itch, anti-infectives, products that alleviate pain, animal health diagnostics, as well as hormones, cardiopulmonary, topical and oral hygiene therapeutics, central nervous system drugs, diuretics, antiemetic, euthanasia, and hepato-digestive products. The company has operations in over 50 countries.
In 2025, 70% of the company's revenue came from products for pets and 29% of the company's revenues came from products for livestock. In 2025, 54% of the company's revenue came from customers in the United States. Of this revenue, 79% came from products for dogs and cats, 13% came from products for cattle, and 4% came from products for horses. In 2025, 46% of the company's revenue came from international customers. Of this revenue, 53% came from products for dogs and cats, 19% came from products for cattle, 9% came from products for swine, 7% came from products for poultry, and 3% came from products for horses.
The firm is named Zoetis in allusion to the Greek-derived zoological term zoetic, meaning "pertaining to life". The company was owned by Pfizer until 2013.
History
1950s to 2000s
In the 1950s, Pfizer began research on several drugs, including oxytetracycline, which was found to be effective in livestock.
In 1952, the Pfizer Agriculture Division opened a 732-acre research and development facility in Terre Haute, Indiana, called Vigo.
In 1988, the division was renamed Pfizer Animal Health.
In 1995, Pfizer acquired Norden Laboratories from GlaxoSmithKline for $1.45 billion, expanding its animal health division into small animal care, including pets.
Secondary research and development centres were opened in Kalamazoo, Michigan, in 2003.
In April 2003, Pfizer acquired Pharmacia Corporation for $60 billion in stock. Pfizer absorbed its animal health assets, which included the legacy operations of The Upjohn Company, into Pfizer Animal Health.
In December 2006, Pfizer Animal Health acquired Embrex, which provides inoculations for poultry against various diseases, for $155 million.
In March 2008, Pfizer Animal Health acquired Catapult Genetics, a developer of livestock DNA tests and gene markers, and Bovigen, which markets DNA technology.
In April 2008, Pfizer Animal Health acquired vaccine products from Schering-Plough.
In June 2009, Pfizer Animal Health acquired Vetnex Animal Health from ICICI Bank.
In October 2009, Pfizer acquired Wyeth, including its subsidiary Fort Dodge Animal Health, which was added to Pfizer Animal Health. Some assets were sold to Boehringer Ingelheim to gain regulatory approval for the transaction.
In May 2010, Pfizer Animal Health acquired Microtek, a developer of aquaculture vaccines.
2010s-present
In January 2011, Pfizer Animal Health acquired Synbiotics, a developer of immunodiagnostic tests for companion and food production animals, for $20 million.
In February 2011, Pfizer acquired King Pharmaceuticals; its Alpharma subsidiary was integrated into Pfizer Animal Health.
In June 2012, Pfizer Animal Health was renamed Zoetis.
In February 2013, Zoetis became a public company via an initial public offering, raising $2.2 billion. Most of the money raised through the IPO was used to pay off existing Pfizer debt. In June 2013, Pfizer divested itself of its remaining shares in Zoetis.
In February 2015, the company acquired a portfolio of pet drugs from Abbott Laboratories for approximately $255 million.
In July 2015, the company acquired KL Automation, a robotics company specializing in automation technology for poultry hatchery.
In November 2015, the company announced it would acquire Pharmaq, a developer of aquaculture treatments and diseases, for $765 million.
In August 2016, the company acquired Scandinavian Micro Biodevices for $80 million.
In April 2017, Zoetis acquired Ireland-based Nexvet, a company with a biologics focused technology and product candidate pipeline.
In July 2018, the company acquired Abaxis for $1.9 billion in cash.
In June 2022, Zoetis acquired Basepaws, a privately held genetics company.
In August 2022, the company acquired Newmetrica, a Scottish company that develops digital tools designed to measure health-related quality of life.
In September 2022, Zoetis acquired Jurox, which develops 150 medicines including Alfaxan.
In August 2023, the company opened a 1.4 million square foot facility on 145 acres in Lincoln, Nebraska.
In September 2023, Zoetis acquired Petmedix, a privately held Cambridge, UK-based company, to bring the benefits of species-specific antibody therapies to pet owners.
In December 2023, Zoetis acquired adivo, a German manufacturer of antibodies for pet medicine.
In October 2024, the company sold its medicated feed additive product portfolio and certain water-soluble products to Phibro Animal Health.
In February 2025, the United States Department of Agriculture granted Zoetis conditional approval to deploy its bird flu vaccine in poultry, after a bird flu outbreak had infected nearly 70 people in the USA, resulting in one death, with most cases occurring among farm workers exposed to infected poultry or cattle. In January 2025, the USDA announced plans to replenish its bird flu vaccine stockpile for poultry, aligning with the strain affecting commercial and wild bird populations, similar to efforts following major outbreaks in 2014 and 2015.
In November 2025, the company acquired Veterinary Pathology Group.
In March 2026, the company agreed to acquired the genomics business of Neogen.
In July 2026, the company agreed to acquire VitalRADS, a veterinary teleradiology platform.
Products
Zoetis' manufacturing network, includes 28 sites in 11 countries. Each facility is designed to meet chemical and infectious agent safety regulatory requirements. Many R&D operations are co-located with manufacturing sites, a collaboration that allows bringing new products to market faster.
Zoetis products include:
Kaynak: Wikipedia (İngilizce), CC BY-SA 4.0 · Wikipedia'da Görüntüle ↗
sektörHealthcare
endüstriPharmaceuticals
çalışanlar14.500
ülkeUS
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir$9.47B2016-12-31 → 2025-12-31
Hisse Başına Kâr$6.022016-12-31 → 2025-12-31
Serbest Nakit Akışı$2.28B2016-12-31 → 2025-12-31
Net kar marjı27.5%2016-12-31 → 2025-12-31
Değerleme ve Oranlar
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | ZTS | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| P/E (TTM) | 11.55Y ort. ≈35.9 | ≈35.9 | 31.0 | Düşük değerli | |
| F/S (TTM) | 3.05Y ort. ≈9.5 | ≈9.5 | · | · | |
| F/D (MRQ) | 9.25Y ort. ≈18.1 | ≈18.1 | · | · | |
| Fiyat / Serbest Nakit Akışı (TTM) | 12.25Y ort. ≈45.7 | ≈45.7 | · | · | |
| Fiyat / Nakit Akışı (TTM) | 10.05Y ort. ≈33.9 | ≈33.9 | · | · | |
| EV / Gelir (TTM) | 3.8 | · | · | · | |
| EV / FCF (TTM) | 15.3 | · | · | · | |
| Fiyat / Maddi Defter Değeri (MRQ) | 12.95Y ort. ≈180.4 | ≈180.4 | · | · | |
| PEG Ratio (PEG Oranı) | ≈1.0 | · | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | ZTS | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| EBITDA Margin (FAVÖK Marjı) | 5.1%5Y ort. ≈5.6% | ≈5.6% | 8.3% | Zayıf | |
| Vergi Öncesi Kar Marjı (TTM) | 34.4%5Y ort. ≈33.7% | ≈33.7% | 15.0% | En üst düzey | |
| Net Kâr Marjı (TTM) | 27.5%5Y ort. ≈27.0% | ≈27.0% | 10.4% | En üst düzey | |
| ROA (TTM) | 17.7%5Y ort. ≈16.2% | ≈16.2% | 9.8% | En üst düzey | |
| ROE (TTM) | 64.4%5Y ort. ≈52.6% | ≈52.6% | 25.3% | En üst düzey |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | ZTS | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Borç / Öz Sermaye (MRQ) | 2.95Y ort. ≈1.7 | ≈1.7 | 0.9 | Yüksek borç | |
| Cari Oran (MRQ) | 3.15Y ort. ≈2.9 | ≈2.9 | 1.6 | Güçlü likidite | |
| Cari Oran (MRQ) | 1.65Y ort. ≈0.6 | ≈0.6 | 0.8 | Güçlü likidite | |
| Uzun Vadeli Borç / Özkaynak (MRQ) | 2.95Y ort. ≈1.6 | ≈1.6 | 0.9 | Yüksek borç |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
| Metrik | 5 Yıllık trend | ZTS | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Revenue YoY (Gelir Yıllık Bazda) | 2.3%5Y ort. ≈7.3% | ≈7.3% | · | · | |
| Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı) | 5.4%5Y ort. ≈6.7% | ≈6.7% | · | · | |
| Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı) | 7.2% | · | · | · | |
| EPS YoY (EPS YB) | 10.1%5Y ort. ≈12.2% | ≈12.2% | · | · | |
| Net Income YoY (Net Gelir Yıllık Bazda) | 7.5%5Y ort. ≈10.5% | ≈10.5% | · | · | |
| EPS CAGR 3Y (EPS Bileşik Yıllık Büyüme Oranı 3Y) | 10.3%5Y ort. ≈11.0% | ≈11.0% | · | · | |
| EPS CAGR 5Y (EPS Bileşik Yıllık Büyüme Oranı 5Y) | 12.0% | · | · | · | |
| Net Income CAGR 3Y (Net Gelir Bileşik Yıllık Büyüme Oranı 3Y) | 8.1%5Y ort. ≈9.2% | ≈9.2% | · | · | |
| Net Income CAGR 5Y (Net Gelir Bileşik Yıllık Büyüme Oranı 5Y) | 10.3% | · | · | · |
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
| Metrik | 5 Yıllık trend | ZTS | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Asset Turnover (Aktif Devir Hızı) | 0.65Y ort. ≈0.6 | ≈0.6 | 0.5 | En üst düzey | |
| Inventory Turnover (Stok Devir Hızı) | 1.15Y ort. ≈1.1 | ≈1.1 | 1.5 | Zayıf | |
| Receivables Turnover (Alacak Devir Hızı) | 6.55Y ort. ≈6.9 | ≈6.9 | 5.6 | En üst düzey | |
| Revenue / Employee (Çalışan Başına Gelir) | ≈$652.9K | · | · | · |
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Temettüler Temettü verimi, ödeme oranı, temettü geçmişi, 5 Yıllık CAGR
Yıllıklaştırılmış Ödeme≈$2.12
5 Yıllık Temettü CAGR≈20.1%
Büyüme Serisi≈11
| Ex-tarihi | Miktar | Para Birimi | Temettü Verimi |
|---|---|---|---|
| Tem 20, 2026 | $0,53 | USD | ≈2.7% |
| Nis 20, 2026 | $0,53 | USD | ≈1.7% |
| Oca 20, 2026 | $0,53 | USD | ≈1.6% |
| Eki 31, 2025 | $0,50 | USD | ≈1.4% |
| Tem 18, 2025 | $0,50 | USD | ≈1.3% |
| Nis 21, 2025 | $0,50 | USD | ≈1.3% |
| Oca 21, 2025 | $0,50 | USD | ≈1.1% |
| Eki 31, 2024 | $0,43 | USD | ≈0.97% |
| Tem 18, 2024 | $0,43 | USD | ≈0.93% |
| Nis 18, 2024 | $0,43 | USD | ≈1.1% |
| Oca 18, 2024 | $0,43 | USD | ≈0.82% |
| Eki 31, 2023 | $0,38 | USD | ≈0.96% |
| Tem 20, 2023 | $0,38 | USD | ≈0.84% |
| Nis 20, 2023 | $0,38 | USD | ≈0.80% |
| Oca 19, 2023 | $0,38 | USD | ≈0.83% |
| Eki 31, 2022 | $0,33 | USD | ≈0.86% |
| Tem 20, 2022 | $0,33 | USD | ≈0.70% |
| Nis 20, 2022 | $0,33 | USD | ≈0.61% |
| Oca 19, 2022 | $0,33 | USD | ≈0.54% |
| Eki 28, 2021 | $0,25 | USD | ≈0.47% |
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
2.5%
Sonraki Rapor
Kas 05, 2026
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 30 Haziran 2026 | Ağu 6, 2026 | $1.87 | $1.87 | -0.22% |
| 31 Mart 2026 | $1.53 | $1.63 | -6.2% | |
| 31 Aralık 2025 | $1.48 | $1.42 | 4.5% | |
| 30 Eylül 2025 | $1.70 | $1.64 | 3.8% | |
| 30 Haziran 2025 | $1.76 | $1.63 | 7.8% | |
| 31 Mart 2025 | $1.48 | $1.41 | 5.2% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $9.47B | $9.26B | $8.54B | $8.08B | $7.78B | $6.67B | $6.26B | $5.83B | $5.31B | $4.89B | $4.76B | $4.79B | |
| Cost of Revenue | $2.67B | $2.72B | $2.56B | $2.45B | $2.30B | $2.06B | $1.99B | $1.91B | $1.77B | $1.67B | $1.74B | $1.72B | |
| SG&A Expense | $2.38B | $2.32B | $2.15B | $2.01B | $2.00B | $1.73B | $1.64B | $1.48B | $1.33B | $1.36B | $1.53B | $1.64B | |
| Interest Expense | $222M | $225M | $239M | $221M | $224M | $231M | $223M | $206M | $175M | $166M | $124M | $117M | |
| Other Non-op | $-6M | $-4M | $-2M | $14M | $-4M | $-5M | $0 | $15M | $1M | $2M | $5M | $-3M | |
| Pretax Income | $3.36B | $3.13B | $2.94B | $2.66B | $2.49B | $2.00B | $1.80B | $1.69B | $1.52B | $1.23B | $545M | $820M | |
| Income Tax | $687M | $637M | $596M | $545M | $454M | $360M | $301M | $266M | $663M | $409M | $206M | $233M | |
| Net Income | $2.67B | $2.49B | $2.34B | $2.11B | $2.04B | $1.64B | $1.50B | $1.43B | $864M | $821M | $339M | $583M | |
| EPS (Basic) | $6.03 | $5.47 | $5.08 | $4.51 | $4.29 | $3.44 | $3.14 | $2.96 | $1.76 | $1.66 | $0.68 | $1.16 | |
| EPS (Diluted) | $6.02 | $5.47 | $5.07 | $4.49 | $4.27 | $3.42 | $3.11 | $2.93 | $1.75 | $1.65 | $0.68 | $1.16 | |
| Shares (Basic) | 443,443,000 | 454,200,000 | 461,172,000 | 468,891,000 | 474,348,000 | 475,502,000 | 478,128,000 | 483,063,000 | 489,918,000 | 495,715,000 | 499,707,000 | 501,055,000 | |
| Shares (Diluted) | 443,835,000 | 454,848,000 | 462,269,000 | 470,385,000 | 476,717,000 | 478,569,000 | 481,787,000 | 486,898,000 | 493,161,000 | 498,225,000 | 502,019,000 | 502,025,000 | |
| EBITDA | $487M | $497M | $491M | $465M | $448M | $441M | $412M | $308M | $242M | $240M | $199M | $204M |
Bilanço
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $2.45B | $1.99B | $2.04B | $3.58B | $3.48B | $3.60B | $1.93B | $1.60B | $1.56B | $727M | $1.15B | $882M | |
| Short-term Investments | $0 | · | · | · | · | · | $0 | $99M | $0 | · | · | · | |
| Receivables | $1.41B | $1.32B | $1.30B | $1.22B | $1.13B | $1.01B | $1.09B | $1.04B | $998M | $913M | $937M | $980M | |
| Inventory | $2.46B | $2.31B | $2.56B | $2.35B | $1.92B | $1.63B | $1.41B | $1.39B | $1.43B | $1.50B | $1.47B | $1.29B | |
| Other Current Assets | $450M | $377M | $434M | $365M | $389M | $366M | $318M | $271M | $228M | $248M | $201M | $205M | |
| Current Assets | $6.77B | $5.99B | $6.34B | $7.51B | $6.93B | $6.61B | $4.75B | $4.40B | $4.22B | $3.39B | $3.83B | $3.46B | |
| PP&E (Net) | $3.69B | $3.39B | $3.20B | $2.75B | $2.42B | $2.20B | $1.94B | $1.66B | $1.44B | $1.38B | $1.31B | $1.32B | |
| PP&E (Gross) | $6.61B | $6.03B | $5.80B | $5.05B | $4.49B | $4.15B | $3.68B | $3.26B | $2.91B | $2.74B | $2.52B | $2.46B | |
| Accum. Depreciation | $2.94B | $2.63B | $2.59B | $2.30B | $2.07B | $1.95B | $1.74B | $1.60B | $1.47B | $1.36B | $1.21B | $1.15B | |
| Goodwill | $2.77B | $2.72B | $2.76B | $2.75B | $2.68B | $2.69B | $2.59B | $2.52B | $1.51B | $1.48B | $1.46B | $976M | |
| Intangibles | $998M | $1.13B | $1.34B | $1.38B | $1.47B | $1.71B | $1.89B | $2.05B | $1.27B | $1.23B | $1.19B | $727M | |
| Other Non-current Assets | $327M | $250M | $206M | $147M | $111M | $106M | $98M | $94M | $75M | $73M | $49M | $48M | |
| Total Assets | $15.49B | $14.24B | $14.29B | $14.93B | $13.90B | $13.61B | $11.54B | $10.78B | $8.59B | $7.65B | $7.91B | $6.59B | |
| Accounts Payable | $445M | $433M | $411M | $405M | $436M | $457M | $301M | $313M | $261M | $265M | $293M | $290M | |
| Accrued Liabilities | $852M | $746M | $683M | $682M | $710M | $556M | $543M | $487M | $432M | $464M | $676M | $475M | |
| Short-term Debt | $0 | $0 | $3M | $2M | $0 | $4M | $0 | $9M | $0 | $0 | $0 | $0 | |
| Current Liabilities | $2.17B | $3.41B | $1.89B | $3.17B | $1.80B | $2.17B | $1.81B | $1.22B | $1.09B | $1.12B | $1.78B | $1.09B | |
| Capital Leases | $197M | $174M | $188M | $186M | $151M | $163M | $164M | $0 | · | · | · | · | |
| Deferred Tax | $137M | $167M | $146M | $142M | $320M | $378M | $434M | $474M | $380M | $244M | $264M | $277M | |
| Other Non-current Liabilities | $250M | $222M | $237M | $217M | $239M | $270M | $229M | $187M | $201M | $248M | $251M | $207M | |
| Total Liabilities | $12.07B | $9.47B | $9.29B | $10.52B | $9.36B | $9.84B | $8.84B | $8.59B | $6.80B | $6.15B | $6.82B | $5.25B | |
| Long-term Debt | $9.04B | $6.57B | $6.56B | $7.90B | $6.59B | $7.20B | $6.45B | $6.44B | $4.95B | $4.47B | $4.86B | $3.62B | |
| Total Debt | $9.04B | $6.57B | $6.57B | $7.90B | $6.59B | $7.20B | $6.45B | $6.45B | $4.95B | $4.47B | $4.86B | · | |
| Common Stock | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | |
| Paid-in Capital | $1.10B | $1.18B | $1.13B | $1.09B | $1.07B | $1.06B | $1.04B | $1.03B | $1.01B | $1.02B | $1.01B | $958M | |
| Retained Earnings | $13.80B | $11.97B | $10.29B | $8.67B | $7.19B | $5.66B | $4.43B | $3.27B | $2.11B | $1.48B | $876M | $709M | |
| Treasury Stock | $10.69B | $7.45B | $5.60B | $4.54B | $2.95B | $2.23B | $2.04B | $1.49B | $852M | $421M | $203M | $0 | |
| AOCI | $-804M | $-940M | $-839M | $-817M | $-764M | $-730M | $-726M | $-629M | $-505M | $-598M | $-622M | $-361M | |
| Stockholders' Equity | $3.42B | $4.77B | $5.00B | $4.41B | $4.54B | $3.77B | $2.71B | $2.19B | $1.79B | $1.50B | $1.07B | $1.31B | |
| Liabilities + Equity | $15.49B | $14.24B | $14.29B | $14.93B | $13.90B | $13.61B | $11.54B | $10.78B | $8.59B | $7.65B | $7.91B | $6.59B | |
| Shares Outstanding | 424,927,535 | 448,473,073 | 458,367,358 | 463,808,059 | 472,574,090 | 475,317,751 | 475,528,210 | 479,562,326 | 486,130,461 | 492,855,297 | 497,400,113 | 501,327,524 |
Nakit Akışı
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $487M | $497M | $491M | $465M | $448M | $441M | $412M | $308M | $242M | $240M | $199M | $204M | |
| Stock-based Comp | $83M | $74M | $60M | $62M | $58M | $59M | $67M | $53M | $44M | $37M | $43M | $32M | |
| Deferred Tax | $-52M | $-338M | $-61M | $-286M | $-80M | $-62M | $-79M | $-112M | $127M | $-55M | $-85M | $-49M | |
| Amort. of Intangibles | $157M | $170M | $185M | $193M | $204M | $230M | $237M | $157M | $100M | $95M | $64M | $63M | |
| Restructuring | $49M | $43M | $46M | $6M | $33M | $8M | $33M | $26M | $13M | $2M | $301M | $17M | |
| Other Non-cash | $-287M | $234M | $-481M | $-443M | $-250M | $50M | $-105M | $113M | $69M | $-330M | $168M | $-144M | |
| Operating Cash Flow | $2.90B | $2.95B | $2.35B | $1.91B | $2.21B | $2.13B | $1.79B | $1.79B | $1.35B | $713M | $664M | $626M | |
| CapEx | $621M | $655M | $732M | $586M | $477M | $453M | $460M | $338M | $224M | $216M | $224M | $180M | |
| Investing Cash Flow | $-748M | $-315M | $-777M | $-883M | $-458M | $-572M | $-504M | $-2.26B | $-270M | $-214M | $-1.11B | $-187M | |
| Net Debt Issued | $-1.35B | $0 | $-1.35B | $0 | $-600M | $-500M | $0 | $0 | $-750M | $-400M | · | · | |
| Stock Repurchased | $3.23B | $1.86B | $1.09B | $1.59B | $743M | $250M | $626M | $698M | $500M | $300M | $203M | $0 | |
| Net Stock Activity | $-3.23B | $-1.86B | $-1.09B | $-1.59B | $-743M | $-250M | $-626M | $-698M | $-500M | $-300M | $-203M | · | |
| Financing Cash Flow | $-1.87B | $-2.66B | $-3.11B | $-904M | $-1.86B | $123M | $-951M | $533M | $-251M | $-903M | $755M | $-154M | |
| Net Change in Cash | $325M | $-54M | $-1.54B | $96M | $-119M | $1.67B | $332M | $38M | $837M | $-427M | $272M | $272M | |
| Taxes Paid | $715M | $892M | $754M | $638M | $548M | $418M | $418M | $336M | $455M | $408M | $224M | $278M | |
| Free Cash Flow | $2.28B | $2.30B | $1.62B | $1.33B | $1.74B | $1.67B | $1.33B | $1.45B | $1.12B | $497M | $440M | $446M | |
| Levered FCF | $2.11B | $2.12B | $1.43B | $1.15B | $1.55B | $1.48B | $1.15B | $1.28B | $1.02B | $386M | $363M | $362M |
Kârlılık
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Margin | 28.2% | 26.9% | 27.4% | 26.2% | 26.2% | 24.5% | 24.0% | 24.5% | 16.3% | 16.8% | 7.1% | 12.2% | |
| Pretax Margin | 35.5% | 33.9% | 34.4% | 32.9% | 32.0% | 29.9% | 28.8% | 29.0% | 28.7% | 25.1% | 11.4% | 17.1% | |
| EBITDA Margin | 5.1% | 5.4% | 5.8% | 5.8% | 5.8% | 6.6% | 6.6% | 5.3% | 4.6% | 4.9% | 4.2% | 4.3% | |
| ROA | 18.0% | 17.4% | 16.1% | 14.7% | 14.8% | 13.0% | 13.4% | 14.7% | 10.6% | 10.5% | 4.7% | · | |
| ROE | 66.0% | 50.9% | 49.9% | 47.2% | 49.0% | 50.6% | 58.6% | 66.4% | 52.9% | 64.3% | 28.5% | · |
Likidite ve Solventlik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.0 | 1.8 | 3.4 | 2.4 | 3.9 | 3.0 | 2.6 | 3.6 | 3.9 | 3.0 | 2.2 | · | |
| Quick Ratio | 0.7 | 0.4 | 0.7 | 0.4 | 0.6 | 0.5 | 0.6 | 0.9 | 2.3 | 1.5 | 1.2 | · | |
| Debt / Equity | 2.7 | 1.4 | 1.3 | 1.8 | 1.5 | 1.9 | 2.4 | 3.0 | 2.8 | 3.0 | 4.6 | · | |
| LT Debt / Equity | 2.7 | 1.1 | 1.3 | 1.5 | 1.5 | 1.7 | 2.2 | 2.9 | 2.8 | 3.0 | 4.2 | · |
Verimlilik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.5 | 0.6 | 0.6 | 0.7 | 0.6 | 0.7 | · | |
| Inventory Turnover | 1.1 | 1.1 | 1.0 | 1.1 | 1.3 | 1.4 | 1.4 | 1.4 | 1.2 | 1.1 | 1.3 | · | |
| Receivables Turnover | 6.5 | 7.1 | 6.8 | 6.9 | 7.2 | 6.4 | 5.9 | 5.7 | 5.6 | 5.3 | 5.0 | · |
Hisse Başına
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $7.84 | $10.64 | $10.90 | $9.50 | $9.61 | $7.93 | $5.69 | $4.56 | $3.64 | $3.02 | $2.15 | · | |
| Revenue / Share | $21.33 | $20.35 | $18.48 | $17.18 | $16.31 | $13.95 | $12.99 | $11.96 | $10.76 | $9.81 | $9.49 | $9.53 | |
| Cash Flow / Share | $6.54 | $6.49 | $5.09 | $4.06 | $4.64 | $4.44 | $3.73 | $3.68 | $2.73 | $1.43 | $1.32 | $1.25 | |
| Cash / Share | · | · | · | · | · | · | · | · | $3.22 | $1.48 | $2.32 | · | |
| Dividend Paid / Share | $2.03 | $1.80 | $1.56 | $1.35 | $1.07 | $0.85 | $0.69 | $0.54 | $0.44 | $0.39 | $0.34 | $0.30 | |
| EPS (TTM) | $6.02 | $5.47 | $5.07 | $4.49 | $4.27 | $3.42 | $3.11 | $2.93 | $1.75 | $1.65 | $0.68 | $1.16 |
Büyüme Oranları
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 2.3% | 8.3% | 5.7% | 3.9% | 16.5% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 5.4% | 6.0% | 8.6% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 7.2% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 10.1% | 7.9% | 12.9% | 5.1% | 24.9% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | 10.3% | 8.6% | 14.0% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 12.0% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 7.5% | 6.1% | 10.9% | 3.8% | 24.4% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 8.1% | 6.9% | 12.7% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 10.3% | · | · | · | · | · | · | · | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $9.47B | $9.26B | $8.54B | $8.08B | $7.78B | $6.67B | $6.26B | $5.83B | $5.31B | $4.89B | $4.76B | $4.79B | |
| Net Income TTM | $2.67B | $2.49B | $2.34B | $2.11B | $2.04B | $1.64B | $1.50B | $1.43B | $864M | $821M | $339M | $583M | |
| Market Cap | $53.46B | $73.07B | $90.47B | $67.97B | $115.32B | $78.67B | $62.94B | $41.02B | $35.02B | $26.38B | $23.84B | · | |
| Enterprise Value | · | · | · | · | · | · | · | · | $38.41B | $30.12B | $27.54B | · | |
| P/E | 20.9 | 29.8 | 38.9 | 32.6 | 57.1 | 48.4 | 42.6 | 29.2 | 41.2 | 32.4 | 70.5 | 37.1 | |
| P/S | 5.6 | 7.9 | 10.6 | 8.4 | 14.8 | 11.8 | 10.1 | 7.0 | 6.6 | 5.4 | 5.0 | · | |
| P/B | 16.1 | 15.3 | 18.1 | 15.4 | 25.4 | 20.9 | 23.2 | 18.8 | 19.8 | 17.7 | 22.3 | · | |
| P / Tangible Book | · | 79.5 | 100.5 | 243.6 | 298.0 | · | · | · | · | · | · | · | |
| P / Cash Flow | 18.4 | 24.7 | 38.4 | 35.5 | 52.1 | 37.0 | 35.1 | 22.9 | 26.0 | 37.0 | 35.9 | · | |
| P / FCF | 23.4 | 31.8 | 55.8 | 51.3 | 66.4 | 47.0 | 47.1 | 28.3 | 31.2 | 53.1 | 54.2 | · | |
| EV / EBITDA | · | · | · | · | · | · | · | · | 158.7 | 125.5 | 138.4 | · | |
| EV / FCF | · | · | · | · | · | · | · | · | 34.2 | 60.6 | 62.6 | · | |
| EV / Revenue | · | · | · | · | · | · | · | · | 7.2 | 6.2 | 5.8 | · | |
| Earnings Yield | 4.8% | 3.4% | 2.6% | 3.1% | 1.8% | 2.1% | 2.4% | 3.4% | 2.4% | 3.1% | 1.4% | 2.7% |
Gelir Tablosu
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.47B | $2.26B | $2.39B | $2.40B | $2.47B | $2.20B | $2.32B | $2.39B | $2.36B | $2.19B | $2.21B | $2.15B | $2.18B | $2.00B | $2.04B | $2.00B | |
| Cost of Revenue | $673M | $641M | $712M | $683M | $664M | $618M | $707M | $701M | $668M | $643M | $728M | $638M | $607M | $588M | $653M | $607M | |
| SG&A Expense | $592M | $588M | $619M | $579M | $614M | $574M | $625M | $565M | $581M | $547M | $565M | $525M | $556M | $505M | $514M | $501M | |
| Interest Expense | $61M | $62M | $57M | $58M | $53M | $54M | $51M | $57M | $59M | $58M | $59M | $59M | $58M | $63M | $62M | $53M | |
| Other Non-op | $-2M | $-1M | $-8M | $0 | $-1M | $3M | $1M | $-2M | $2M | $-5M | $5M | $-4M | $2M | $-5M | $6M | $1M | |
| Pretax Income | $866M | $758M | $761M | $887M | $912M | $773M | $732M | $874M | $780M | $747M | $650M | $717M | $872M | $697M | $592M | $667M | |
| Income Tax | $175M | $157M | $158M | $166M | $186M | $171M | $151M | $182M | $156M | $148M | $127M | $121M | $202M | $146M | $132M | $139M | |
| Net Income | $691M | $601M | $603M | $721M | $726M | $602M | $581M | $682M | $624M | $599M | $525M | $596M | $671M | $552M | $461M | $529M | |
| EPS (Basic) | $1.65 | $1.42 | $1.38 | $1.63 | $1.63 | $1.34 | $1.28 | $1.51 | $1.37 | $1.31 | $1.15 | $1.29 | $1.45 | $1.19 | $0.99 | $1.13 | |
| EPS (Diluted) | $1.65 | $1.42 | $1.37 | $1.63 | $1.63 | $1.34 | $1.29 | $1.50 | $1.37 | $1.31 | $1.14 | $1.29 | $1.45 | $1.19 | $0.98 | $1.13 | |
| Shares (Basic) | 417,600,000 | 422,100,000 | · | 442,900,000 | 445,100,000 | 447,600,000 | · | 452,900,000 | 455,500,000 | 458,000,000 | · | 460,300,000 | 461,900,000 | 463,500,000 | · | 467,800,000 | |
| Shares (Diluted) | 417,700,000 | 422,400,000 | · | 443,200,000 | 445,500,000 | 448,000,000 | · | 453,500,000 | 456,000,000 | 458,800,000 | · | 461,400,000 | 462,900,000 | 464,600,000 | · | 469,100,000 | |
| EBITDA | $119M | $119M | · | $124M | $123M | $119M | · | $121M | $127M | $126M | · | $124M | $121M | $120M | · | $115M |
Bilanço
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.48B | $1.94B | · | $2.08B | $1.44B | $1.72B | · | $1.71B | $1.57B | $1.98B | · | $1.75B | $1.72B | $2.11B | · | $2.51B | |
| Short-term Investments | $200M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Receivables | $1.57B | $1.51B | $1.59B | $1.54B | $1.54B | $1.36B | $1.32B | $1.41B | $1.38B | $1.29B | · | $1.26B | $1.32B | $1.19B | · | $1.19B | |
| Inventory | $2.57B | $2.55B | $2.43B | $2.46B | $2.44B | $2.37B | $2.31B | $2.42B | $2.45B | $2.65B | · | $2.74B | $2.70B | $2.56B | · | $2.30B | |
| Other Current Assets | $535M | $477M | $436M | $493M | $509M | $430M | $377M | $427M | $467M | $440M | · | $467M | $443M | $411M | · | $552M | |
| Current Assets | $6.36B | $6.47B | $6.77B | $6.58B | $5.92B | $5.88B | $5.99B | $6.28B | $6.20B | $6.36B | · | $6.22B | $6.18B | $6.27B | · | $6.55B | |
| PP&E (Net) | $3.76B | $3.72B | $3.68B | $3.60B | $3.54B | $3.44B | $3.39B | $3.30B | $3.20B | $3.25B | · | $3.09B | $3.01B | $2.91B | · | $2.62B | |
| PP&E (Gross) | · | · | $6.61B | · | · | · | $6.03B | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | $3.07B | $3.00B | $2.92B | $2.87B | $2.80B | $2.70B | $2.63B | $2.66B | $2.59B | $2.67B | · | $2.53B | $2.45B | $2.37B | · | $2.23B | |
| Goodwill | $2.77B | $2.78B | $2.77B | $2.76B | $2.76B | $2.72B | $2.72B | $2.74B | $2.74B | $2.76B | $2.76B | $2.76B | $2.71B | $2.74B | $2.75B | $2.69B | |
| Intangibles | $918M | $959M | $998M | $1.04B | $1.07B | $1.08B | $1.13B | $1.19B | $1.23B | $1.29B | · | $1.40B | $1.25B | $1.31B | · | $1.32B | |
| Other Non-current Assets | $384M | $351M | $328M | $293M | $267M | $232M | $250M | $215M | $210M | $227M | · | $216M | $173M | $143M | · | $161M | |
| Total Assets | $15.08B | $15.15B | $15.47B | $15.16B | $14.48B | $14.10B | $14.24B | $14.36B | $14.16B | $14.35B | · | $14.11B | $13.75B | $13.75B | · | $13.67B | |
| Accounts Payable | $452M | $507M | $487M | $410M | $508M | $420M | $433M | $404M | $420M | $405M | · | $388M | $464M | $424M | · | $373M | |
| Accrued Liabilities | · | · | $852M | · | · | · | $746M | · | · | · | · | · | · | · | · | · | |
| Short-term Debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $24M | · | $2M | $2M | $3M | · | $3M | |
| Current Liabilities | $2.06B | $2.05B | $2.23B | $1.81B | $3.37B | $3.38B | $3.41B | $1.70B | $1.80B | $1.91B | · | $1.61B | $1.77B | $1.92B | · | $2.88B | |
| Capital Leases | $190M | $193M | $196M | $204M | $210M | $173M | $174M | $181M | $181M | $184M | · | $191M | $188M | $180M | · | $186M | |
| Deferred Tax | $122M | $130M | $139M | $147M | $156M | $161M | $167M | $172M | $175M | $136M | · | $160M | $121M | $131M | · | $256M | |
| Other Non-current Liabilities | $220M | $219M | $248M | $264M | $274M | $220M | $222M | $220M | $222M | $228M | · | $259M | $217M | $216M | · | $239M | |
| Total Liabilities | $11.93B | $11.92B | $12.14B | $9.76B | $9.50B | $9.44B | $9.47B | $9.12B | $9.21B | $9.30B | · | $9.03B | $9.13B | $9.26B | · | $9.01B | |
| Long-term Debt | · | · | $9.04B | $7.07B | $6.58B | $6.58B | $6.57B | · | · | · | · | $6.55B | $6.55B | $6.56B | · | $6.56B | |
| Total Debt | $9.05B | $9.04B | · | $7.07B | $6.58B | $6.58B | · | $6.57B | $6.56B | $6.59B | · | $6.55B | $6.56B | $6.56B | · | $6.56B | |
| Common Stock | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | · | $5M | $5M | $5M | · | $5M | |
| Paid-in Capital | $1.13B | $1.10B | $1.10B | $1.22B | $1.20B | $1.18B | $1.18B | $1.16B | $1.15B | $1.13B | · | $1.12B | $1.10B | $1.08B | · | $1.07B | |
| Retained Earnings | $14.65B | $14.18B | $13.74B | $13.59B | $12.87B | $12.38B | $11.97B | $11.81B | $11.12B | $10.70B | · | $10.14B | $9.54B | $9.04B | · | $8.53B | |
| Treasury Stock | $11.85B | $11.29B | $10.69B | $8.61B | $8.23B | $7.89B | $7.45B | $6.89B | $6.46B | $5.93B | · | $5.37B | $5.13B | $4.81B | · | $4.14B | |
| AOCI | $-796M | $-772M | $-834M | $-818M | $-877M | $-1.02B | $-940M | $-851M | $-845M | $-841M | · | $-814M | $-895M | $-828M | · | $-809M | |
| Stockholders' Equity | $3.15B | $3.23B | $3.33B | $5.40B | $4.98B | $4.66B | $4.77B | $5.23B | $4.97B | $5.06B | · | $5.08B | $4.62B | $4.49B | · | $4.66B | |
| Liabilities + Equity | $15.08B | $15.15B | $15.47B | $15.16B | $14.48B | $14.10B | $14.24B | $14.36B | $14.16B | $14.35B | · | $14.11B | $13.75B | $13.75B | · | $13.67B | |
| Shares Outstanding | 414,154,046 | 420,348,495 | 424,927,535 | 441,464,339 | 443,945,593 | 446,040,205 | 448,473,073 | 451,549,789 | 453,812,361 | 456,947,205 | · | 459,524,713 | 460,750,652 | 462,495,343 | · | 466,442,095 |
Nakit Akışı
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $119M | $119M | $121M | $124M | $124M | $119M | $123M | $121M | $127M | $126M | $126M | $124M | $121M | $120M | $119M | $115M | |
| Stock-based Comp | $26M | $25M | $22M | $22M | $22M | $17M | $19M | $18M | $19M | $18M | $17M | $17M | $17M | $9M | $16M | $15M | |
| Deferred Tax | $-33M | $34M | $-48M | $-16M | $-7M | $14M | $-152M | $-42M | $-101M | $-43M | $-21M | $-14M | $-34M | $8M | $-176M | $-34M | |
| Amort. of Intangibles | $38M | $39M | $38M | $39M | $40M | $40M | $42M | $42M | $42M | $44M | $44M | $46M | $48M | $47M | $46M | $48M | |
| Restructuring | $75M | $20M | $16M | $4M | · | · | $-3M | $-2M | $37M | $11M | $8M | $13M | $5M | $20M | $1M | · | |
| Other Non-cash | · | $-378M | · | · | · | $-199M | · | · | · | $-105M | · | · | · | $-140M | · | · | |
| Operating Cash Flow | $655M | $401M | $893M | $938M | $486M | $515M | $905M | $951M | $502M | $595M | $897M | $724M | $183M | $549M | $741M | $526M | |
| CapEx | $117M | $110M | $161M | $133M | $178M | $178M | $216M | $167M | $132M | $140M | $198M | $145M | $166M | $223M | $171M | $154M | |
| Investing Cash Flow | $-300M | $-87M | $-166M | $-160M | $-247M | $-203M | $126M | $-178M | $-132M | $-131M | $-210M | $-271M | $-80M | $-216M | $-438M | $-124M | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | $0 | · | · | · | $-1.35B | · | · | |
| Stock Repurchased | $584M | $606M | $2.06B | $394M | $338M | $443M | $553M | $433M | $533M | $339M | $235M | $250M | $324M | $283M | $405M | $377M | |
| Net Stock Activity | · | $-606M | · | · | · | $-443M | · | · | · | $-339M | · | · | · | $-283M | · | · | |
| Financing Cash Flow | $-813M | $-840M | $-495M | $-134M | $-564M | $-677M | $-745M | $-628M | $-763M | $-524M | $-397M | $-416M | $-494M | $-1.80B | $780M | $-529M | |
| Net Change in Cash | $-465M | $-509M | $228M | $649M | $-286M | $-332M | $273M | $140M | $-401M | $-66M | $287M | $37M | $-392M | $-1.47B | $1.07B | $-145M | |
| Taxes Paid | $380M | $50M | $133M | $107M | $428M | $60M | $235M | $176M | $422M | $59M | $168M | $128M | $438M | $20M | $167M | $155M | |
| Free Cash Flow | · | $291M | · | · | · | $438M | · | · | · | $455M | · | · | · | $326M | · | · | |
| Levered FCF | · | $242M | · | · | · | $396M | · | · | · | $408M | · | · | · | $276M | · | · |
Kârlılık
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Margin | 28.0% | 26.6% | · | 30.0% | 29.2% | 28.4% | · | 28.6% | 26.4% | 27.4% | · | 27.7% | 30.8% | 27.6% | · | 26.4% | |
| Pretax Margin | 35.1% | 33.5% | · | 37.0% | 36.7% | 36.5% | · | 36.6% | 33.0% | 34.1% | · | 33.3% | 40.0% | 34.8% | · | 33.3% | |
| EBITDA Margin | 4.8% | 5.3% | · | 5.2% | 5.0% | 5.4% | · | 5.1% | 5.4% | 5.8% | · | 5.8% | 5.5% | 6.0% | · | 5.7% | |
| ROA | 4.7% | 4.1% | · | 4.9% | 5.0% | 4.4% | · | 4.8% | 4.5% | 4.3% | · | 4.3% | 4.9% | 4.0% | · | 3.9% | |
| ROE | 17.0% | 15.2% | · | 13.6% | 14.4% | 13.0% | · | 13.2% | 13.0% | 12.5% | · | 12.2% | 14.6% | 12.1% | · | 11.3% |
Likidite ve Solventlik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.1 | 3.2 | · | 3.6 | 1.8 | 1.7 | · | 3.7 | 3.5 | 3.3 | · | 3.9 | 3.5 | 3.3 | · | 2.3 | |
| Quick Ratio | 1.6 | 1.7 | · | 2.0 | 0.9 | 0.9 | · | 1.8 | 1.6 | 1.7 | · | 1.9 | 1.7 | 1.7 | · | 1.3 | |
| Debt / Equity | 2.9 | 2.8 | · | 1.3 | 1.3 | 1.4 | · | 1.3 | 1.3 | 1.3 | · | 1.3 | 1.4 | 1.5 | · | 1.4 | |
| LT Debt / Equity | 2.9 | 2.8 | · | 1.3 | 1.1 | 1.1 | · | 1.3 | 1.3 | 1.3 | · | 1.3 | 1.4 | 1.5 | · | 1.1 |
Verimlilik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.2 | · | 0.3 | 0.3 | 0.2 | · | 0.3 | 0.2 | 0.3 | · | 0.3 | |
| Receivables Turnover | 1.6 | 1.6 | · | 1.6 | 1.7 | 1.7 | · | 1.8 | 1.7 | 1.8 | · | 1.8 | 1.7 | 1.7 | · | 1.7 |
Hisse Başına
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $7.60 | $7.69 | · | $12.23 | $11.21 | $10.44 | · | $11.59 | $10.94 | $11.07 | · | $11.05 | $10.04 | $9.72 | · | $10.00 | |
| Revenue / Share | $5.91 | $5.36 | · | $5.42 | $5.52 | $4.96 | · | $5.27 | $5.18 | $4.77 | · | $4.66 | $4.71 | $4.30 | · | $4.27 | |
| Cash Flow / Share | · | $0.95 | · | · | · | $1.31 | · | · | · | $1.30 | · | · | · | $1.18 | · | · | |
| Cash / Share | $3.56 | $4.62 | · | $4.72 | $3.23 | $3.86 | · | $3.80 | $3.47 | $4.32 | · | $3.82 | $3.73 | $4.56 | · | $5.37 | |
| Dividend / Share | $0.53 | $0.53 | · | $0.00 | $0.50 | $0.50 | · | $0.00 | $0.43 | $0.43 | · | $0.00 | $0.38 | $0.38 | · | $0.00 | |
| EPS (TTM) | $6.07 | $6.05 | · | $5.89 | $5.76 | $5.50 | · | $5.32 | $5.11 | $5.19 | · | $4.91 | $4.75 | $4.42 | · | $4.38 |
Değerleme (TTM)
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $9.52B | $9.52B | · | $9.39B | $9.38B | $9.26B | · | $9.15B | $8.91B | $8.73B | · | $8.37B | $8.22B | $8.09B | · | $8.01B | |
| Net Income TTM | $2.62B | $2.65B | · | $2.63B | $2.59B | $2.49B | · | $2.43B | $2.34B | $2.39B | · | $2.28B | $2.21B | $2.07B | · | $2.07B | |
| Market Cap | $29.76B | $49.69B | · | $64.60B | $69.23B | $73.44B | · | $88.22B | $78.67B | $77.32B | · | $79.95B | $79.35B | $76.98B | · | $69.17B | |
| Enterprise Value | $37.13B | $56.79B | · | $69.58B | $74.38B | $78.30B | · | $93.08B | $83.66B | $81.93B | · | $84.75B | $84.19B | $81.43B | · | $73.22B | |
| P/E | 11.8 | 19.5 | · | 24.8 | 27.1 | 29.9 | · | 36.7 | 33.9 | 32.6 | · | 35.4 | 36.3 | 37.7 | · | 33.9 | |
| P/S | 3.1 | 5.2 | · | 6.9 | 7.4 | 7.9 | · | 9.6 | 8.8 | 8.9 | · | 9.6 | 9.7 | 9.5 | · | 8.6 | |
| P/B | 9.5 | 15.4 | · | 12.0 | 13.9 | 15.8 | · | 16.9 | 15.8 | 15.3 | · | 15.7 | 17.2 | 17.1 | · | 14.8 | |
| P / Tangible Book | · | · | · | 40.5 | 60.5 | 85.7 | · | 67.7 | 78.6 | 77.0 | · | 87.1 | 120.4 | 174.2 | · | 106.1 | |
| P / Cash Flow | · | 123.9 | · | · | · | 125.1 | · | · | · | 129.9 | · | · | · | 140.2 | · | · | |
| EV / Revenue | 3.9 | 6.0 | · | 7.4 | 7.9 | 8.5 | · | 10.2 | 9.4 | 9.4 | · | 10.1 | 10.2 | 10.1 | · | 9.1 | |
| Earnings Yield | 8.5% | 5.1% | · | 4.0% | 3.7% | 3.3% | · | 2.7% | 2.9% | 3.1% | · | 2.8% | 2.8% | 2.7% | · | 2.9% |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Gelir | $9.47B | $9.26B | $8.54B | $8.08B | $7.78B |
| Net Gelir | $2.67B | $2.49B | $2.34B | $2.11B | $2.04B |
| Seyreltilmiş Hisse Başı Kâr | $6.02 | $5.47 | $5.07 | $4.49 | $4.27 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Borç / Öz Sermaye | 2.7 | 1.4 | 1.3 | 1.8 | 1.5 |
| Cari Oran | 3.0 | 1.8 | 3.4 | 2.4 | 3.9 |
| Cari Oran | 0.7 | 0.4 | 0.7 | 0.4 | 0.6 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $2.28B | $2.30B | $1.62B | $1.33B | $1.74B |
Kurumsal Sahipler (13F) 1.578 dosya · $35.8B toplam · Tarih itibarıyla 30 Eylül 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Sahipler
1.578
Tutulan Değer
$35.8B
Yeni pozisyonlar
170
Çıkan pozisyonlar
318
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 170 (-31 önceki Ç'ye göre) | 318 (+136 önceki Ç'ye göre) | 521 (-88 önceki Ç'ye göre) | 585 (-42 önceki Ç'ye göre) | -6.7M |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| VANGUARD GROUP INC | $6.011.802.148 | 47.780.974 | 16,82% | Hisse senetleri |
| BlackRock, Inc. | $2.833.452.809 | 39.430.181 | 7,93% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $1.870.370.930 | 26.027.984 | 5,23% | Hisse senetleri |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1.714.611.578 | 23.860.445 | 4,80% | Hisse senetleri |
| STATE STREET CORP | $1.413.322.575 | 19.667.723 | 3,95% | Hisse senetleri |
| STATE FARM MUTUAL AUTOMOBILE INSURANCE CO | $1.142.064.009 | 15.892.903 | 3,19% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $951.789.721 | 13.289.622 | 2,66% | Hisse senetleri |
| WELLINGTON MANAGEMENT GROUP LLP | $677.201.094 | 9.423.895 | 1,89% | Hisse senetleri |
| MORGAN STANLEY | $638.034.469 | 8.878.849 | 1,78% | Hisse senetleri |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $519.929.070 | 4.398.351 | 1,45% | Hisse senetleri |
| NORDEA INVESTMENT MANAGEMENT AB | $471.698.956 | 6.592.578 | 1,32% | Hisse senetleri |
| JANUS HENDERSON GROUP PLC | $437.568.419 | 3.701.747 | 1,22% | Hisse senetleri |
| DEUTSCHE BANK AG\ | $420.505.821 | 5.851.737 | 1,18% | Hisse senetleri |
| NORTHERN TRUST CORP | $398.264.934 | 5.542.234 | 1,11% | Hisse senetleri |
| Invesco Ltd. | $396.884.095 | 5.523.018 | 1,11% | Hisse senetleri |
| FIL Ltd | $386.734.926 | 5.381.783 | 1,08% | Hisse senetleri |
| NORGES BANK | $337.012.405 | 4.689.847 | 0,94% | Hisse senetleri |
| VAN ECK ASSOCIATES CORP | $305.558.780 | 4.252.140 | 0,85% | Hisse senetleri |
| FLOSSBACH VON STORCH SE | $302.600.879 | 4.210.978 | 0,85% | Hisse senetleri |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $287.726.761 | 4.003.981 | 0,80% | Hisse senetleri |
| Amundi | $286.622.090 | 3.988.618 | 0,80% | Hisse senetleri |
| BANK OF AMERICA CORP /DE/ | $282.045.207 | 3.924.926 | 0,79% | Hisse senetleri |
| UBS Group AG | $261.803.299 | 3.643.241 | 0,73% | Hisse senetleri |
| Legal & General Group Plc | $256.352.499 | 3.567.388 | 0,72% | Hisse senetleri |
| Diamond Hill Capital Management, LLC (Investment Advisor) | $255.637.351 | 3.557.436 | 0,72% | Hisse senetleri |
| CIBC Private Wealth Group LLC | $246.008.713 | 1.681.306 | 0,69% | Hisse senetleri |
| Bank of New York Mellon Corp | $238.741.846 | 3.322.319 | 0,67% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $229.937.577 | 3.199.799 | 0,64% | Hisse senetleri |
| CITADEL ADVISORS LLC | $229.108.579 | 3.188.263 | 0,64% | Hisse senetleri |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $225.456.582 | 3.137.442 | 0,63% | Hisse senetleri |
| JPMORGAN CHASE & CO | $192.268.534 | 2.624.825 | 0,54% | Hisse senetleri |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | $173.617.784 | 2.416.056 | 0,49% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $170.008.975 | 2.365.836 | 0,48% | Hisse senetleri |
| Ruane, Cunniff & Goldfarb L.P. | $169.108.138 | 2.353.300 | 0,47% | Hisse senetleri |
| BARCLAYS PLC | $165.474.682 | 2.302.737 | 0,46% | Hisse senetleri |
| Qube Research & Technologies Ltd | $163.792.869 | 2.279.333 | 0,46% | Hisse senetleri |
| DIMENSIONAL FUND ADVISORS LP | $156.216.242 | 2.173.278 | 0,44% | Hisse senetleri |
| VICTORY CAPITAL MANAGEMENT INC | $152.540.744 | 2.122.749 | 0,43% | Hisse senetleri |
| JANE STREET GROUP, LLC | $144.534.676 | 2.011.337 | 0,40% | Hisse senetleri |
| BRANDES INVESTMENT PARTNERS, LP | $138.737.455 | 1.930.651 | 0,39% | Hisse senetleri |
| HSBC HOLDINGS PLC | $132.131.854 | 1.839.811 | 0,37% | Hisse senetleri |
| BLS Capital Fondsmaeglerselskab A/S | $131.538.868 | 1.830.488 | 0,37% | Hisse senetleri |
| ROYAL BANK OF CANADA | $131.385.000 | 1.828.326 | 0,37% | Hisse senetleri |
| MILLENNIUM MANAGEMENT LLC | $130.336.722 | 1.813.759 | 0,36% | Hisse senetleri |
| CONFLUENCE INVESTMENT MANAGEMENT LLC | $130.169.165 | 1.864.087 | 0,36% | Hisse senetleri |
| WELLS FARGO & COMPANY/MN | $130.014.751 | 1.809.278 | 0,36% | Hisse senetleri |
| Man Group plc | $129.707.516 | 1.805.003 | 0,36% | Hisse senetleri |
| Nuveen, LLC | $129.322.602 | 1.799.647 | 0,36% | Hisse senetleri |
| BANQUE PICTET & CIE SA | $128.888.455 | 1.793.605 | 0,36% | Hisse senetleri |
| RAYMOND JAMES FINANCIAL INC | $125.134.922 | 1.741.371 | 0,35% | Hisse senetleri |
Aktivistler ve %5+ sahipler 2 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| Pershing Square Capital Management, L.P., PS Management GP, LLC, William A. Ackman ×7 başvurular | 08 Temmuz 2016 | · | İlk başvuru | · | SEC |
| Sachem Head Capital Management LP, Uncas GP LLC, Sachem Head GP LLC, Scott D. Ferguson ×2 başvurular | 04 Şubat 2015 | · | İlk başvuru | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Şirket yöneticileri 52 içeriden öğrenenler · 30 yöneticiler · 21 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Kristin C Peck | Chief Executive Officer | 10 Temmuz 2026 A | 105.068 | 0 | 2 | $-2.540.972 |
| James Saccaro | EVP, CFO & COO | 31 Ağustos 2026 A | · | 0 | 0 | $0 |
| Wetteny Joseph | Chief Financial Officer | 10 Temmuz 2026 A | 22.113 | 0 | 0 | $0 |
| Paul Herendeen | Exec. V.P. and CFO | 19 Temmuz 2016 A | · | 0 | 0 | $0 |
| Julie Fuller | Executive Vice President | 30 Eylül 2026 M | 1.588 | 0 | 0 | $0 |
| Kevin Esch | Executive Vice President | 10 Temmuz 2026 A | 578 | 0 | 0 | $0 |
| Keith Sarbaugh | Executive Vice President | 10 Temmuz 2026 A | 3.346 | 0 | 0 | $0 |
| Rimma Driscoll | Executive Vice President | 10 Temmuz 2026 A | 5.715 | 0 | 0 | $0 |
| Astorga Jeannette Ferran | Executive Vice President | 10 Temmuz 2026 A | 1.684 | 0 | 0 | $0 |
| Abhay U Nayak | Executive Vice President | 10 Temmuz 2026 A | 1.965 | 0 | 0 | $0 |
| Roxanne Lagano | Executive Vice President | 10 Temmuz 2026 A | 15.632 | 0 | 0 | $0 |
| Jamie Brannan | Executive Vice President | 19 Şubat 2026 M | 3.290 | 0 | 0 | $0 |
| Nicholas Ashton | Executive Vice President | 19 Şubat 2026 M | 1.822 | 0 | 0 | $0 |
| Robert J Polzer | Executive Vice President | 10 Ekim 2025 A | 5.120 | 0 | 0 | $0 |
| Soria Ester Banque | Executive Vice President | 04 Ekim 2024 A | 588 | 0 | 0 | $0 |
| Wafaa Mamilli | Executive Vice President | 04 Ekim 2024 A | 6.685 | 0 | 0 | $0 |
| Heidi C. Chen | Executive Vice President | 05 Nisan 2024 A | 31.293 | 0 | 0 | $0 |
| Glenn David | Executive Vice President | 13 Ocak 2023 A | 46.572 | 0 | 0 | $0 |
| Timothy J Bettington | Executive Vice President | 07 Ekim 2022 A | · | 0 | 0 | $0 |
| Roman Trawicki | Executive Vice President | 16 Mart 2022 M | 8.218 | 0 | 0 | $0 |
| Catherine A. Knupp | Executive Vice President | 10 Kasım 2021 S | 43.642 | 0 | 0 | $0 |
| Sherry N Pudloski | Executive Vice President | 08 Ekim 2021 A | · | 0 | 0 | $0 |
| Robert Edward Kelly | Executive Vice President | 03 Mayıs 2021 M | 8.300 | 0 | 0 | $0 |
| James Michael Mcfarland | Executive Vice President | 09 Nisan 2021 A | 2.547 | 0 | 0 | $0 |
| Clinton A. Lewis Jr. | Executive Vice President | 16 Aralık 2019 M | 27.904 | 0 | 0 | $0 |
| Andrew Fenton | Executive Vice President | 06 Aralık 2019 M | 23.073 | 0 | 0 | $0 |
| Alejandro Bernal | Executive Vice President | 27 Şubat 2018 M | 11.417 | 0 | 0 | $0 |
| Sandra J. Beaty | Executive Vice President | 30 Nisan 2015 A | 6.721 | 0 | 0 | $0 |
| Joyce J. Lee | Executive Vice President | 09 Nisan 2015 A | 3.838 | 0 | 0 | $0 |
| Stefan Weiskopf | Executive Vice President | 27 Şubat 2015 A | 3.658 | 0 | 0 | $0 |
| Mark Stetter | Yönetim kurulu üyesi | 17 Eylül 2026 A | 1.572 | 0 | 0 | $0 |
| Frank A Damelio | Yönetim kurulu üyesi | 07 Ağustos 2026 G | 14.808 | 1 | 0 | $501.344 |
| Michael B Mccallister | Yönetim kurulu üyesi | 10 Haziran 2026 G | 0 | 1 | 0 | $233.280 |
| Louise M Parent | Yönetim kurulu üyesi | 20 Mayıs 2026 M | 28.394 | 0 | 0 | $0 |
| Paul Bisaro | Yönetim kurulu üyesi | 13 Mayıs 2026 P | 27.862 | 1 | 0 | $151.760 |
| Gregory Norden | Yönetim kurulu üyesi | 09 Mart 2026 G | 0 | 0 | 0 | $0 |
| Vanessa Broadhurst | Yönetim kurulu üyesi | 19 Şubat 2026 M | 3.920 | 0 | 0 | $0 |
| Antoinette Renee Leatherberry | Yönetim kurulu üyesi | 19 Şubat 2026 M | 5.280 | 0 | 0 | $0 |
| Willie M Reed | Yönetim kurulu üyesi | 19 Şubat 2026 M | 12.864 | 0 | 0 | $0 |
| Gavin Hattersley | Yönetim kurulu üyesi | 19 Şubat 2026 M | 3.354 | 0 | 0 | $0 |
| Khosla Sanjay | Yönetim kurulu üyesi | 19 Şubat 2026 A | 1.892 | 0 | 0 | $0 |
| Stephanie Tilenius | Yönetim kurulu üyesi | 18 Şubat 2026 A | · | 0 | 0 | $0 |
| Robert W Scully | Yönetim kurulu üyesi | 21 Mayıs 2025 M | 21.489 | 0 | 0 | $0 |
| Linda Rhodes | Yönetim kurulu üyesi | 21 Mayıs 2024 M | 11.192 | 0 | 0 | $0 |
| Juan Ramon Alaix | Yönetim kurulu üyesi | 20 Mayıs 2021 D | 215.129 | 0 | 0 | $0 |
| William C Steere JR | Yönetim kurulu üyesi | 20 Mayıs 2021 M | 35.074 | 0 | 0 | $0 |
| Charles H Hill | Yönetim kurulu üyesi | 06 Şubat 2013 P | 5.000 | 0 | 0 | $0 |
| Amy Schulman | Yönetim kurulu üyesi | 06 Şubat 2013 P | 5.000 | 0 | 0 | $0 |
| Douglas E. Giordano | Yönetim kurulu üyesi | 06 Şubat 2013 P | 5.000 | 0 | 0 | $0 |
| Geno J Germano | Yönetim kurulu üyesi | 06 Şubat 2013 P | 5.000 | 0 | 0 | $0 |
| Pfizer Inc. | 10% sahip | 24 Haziran 2013 C | 0 | 0 | 0 | $0 |
| Richard A. Passov | · | 15 Temmuz 2014 A | 3.706 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
ETF sahipliği 154 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| IHE · iShares Trust | 3,78% | 840.871 SH | 11 Eylül 2026 | Günlük |
| SMRI · EA Series Trust | 1,83% | 152.486 NS | 31 Temmuz 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 1,82% | 246.575 NS | 31 Temmuz 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,56% | 196.180 SH | 02 Ekim 2026 | Günlük |
| CZA · Invesco Exchange-Traded Fund Trust | 1,54% | 45.027 SH | 02 Ekim 2026 | Günlük |
| CVAR · ETF Opportunities Trust | 1,40% | 7.761 NS | 31 Temmuz 2026 | N-PORT |
| PILL · Direxion Shares ETF Trust | 1,08% | 2.889 NS | 31 Temmuz 2026 | N-PORT |
| PKW · Invesco Exchange-Traded Fund Trust | 0,91% | 220.756 SH | 02 Ekim 2026 | Günlük |
| QUVU · Hartford Funds Exchange-Traded Trust | 0,74% | 17.243 NS | 31 Temmuz 2026 | N-PORT |
| IWP · iShares Trust | 0,71% | 1.867.940 SH | 11 Eylül 2026 | Günlük |
| COWZ · Pacer Funds Trust | 0,62% | 1.502.929 NS | 31 Temmuz 2026 | N-PORT |
| VOT · VANGUARD INDEX FUNDS | 0,59% | 2.890.747 SH | 19 Ağustos 2026 | Günlük |
| FLAG · Global X Funds | 0,56% | 123 NS | 31 Temmuz 2026 | N-PORT |
| ESLV · Strategy Shares | 0,52% | 951 NS | 31 Temmuz 2026 | N-PORT |
| PABU · iShares Trust | 0,51% | 174.679 SH | 11 Eylül 2026 | Günlük |
| IYH · iShares Trust | 0,49% | 246.300 SH | 11 Eylül 2026 | Günlük |
| FHLC · FIDELITY COVINGTON TRUST | 0,47% | 200.057 NS | 31 Temmuz 2026 | N-PORT |
| RCGE · EA Series Trust | 0,47% | 6.141 NS | 31 Temmuz 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,45% | 1.264.118 SH | 19 Ağustos 2026 | Günlük |
| IXJ · iShares Trust | 0,39% | 219.915 SH | 10 Eylül 2026 | Günlük |
| CURE · Direxion Shares ETF Trust | 0,37% | 8.250 NS | 31 Temmuz 2026 | N-PORT |
| NULC · Nushares ETF Trust | 0,35% | 3.218 NS | 31 Temmuz 2026 | N-PORT |
| ESUM · Strategy Shares | 0,33% | 7.829 NS | 31 Temmuz 2026 | N-PORT |
| FQAL · FIDELITY COVINGTON TRUST | 0,31% | 57.270 NS | 31 Temmuz 2026 | N-PORT |
| BSCS · Invesco Exchange-Traded Self-Indexe… | 0,31% | 10.926.000 | 02 Ekim 2026 | Günlük |
| SUSA · iShares Trust | 0,30% | 164.110 SH | 11 Eylül 2026 | Günlük |
| VFVA · VANGUARD WELLINGTON FUND | 0,29% | 33.789 SH | 19 Ağustos 2026 | Günlük |
| RECS · Columbia ETF Trust I | 0,28% | 212.600 NS | 31 Temmuz 2026 | N-PORT |
| SPHQ · Invesco Exchange-Traded Fund Trust | 0,28% | 754.566 SH | 02 Ekim 2026 | Günlük |
| VO · VANGUARD INDEX FUNDS | 0,26% | 8.177.172 SH | 19 Ağustos 2026 | Günlük |
| EVUS · iShares Trust | 0,25% | 13.282 SH | 11 Eylül 2026 | Günlük |
| IMCV · iShares Trust | 0,25% | 39.931 SH | 11 Eylül 2026 | Günlük |
| DUHP · Dimensional ETF Trust | 0,24% | 375.907 NS | 31 Temmuz 2026 | N-PORT |
| QDF · FlexShares Trust | 0,23% | 67.413 NS | 31 Temmuz 2026 | N-PORT |
| IWR · iShares Trust | 0,23% | 1.725.551 SH | 11 Eylül 2026 | Günlük |
| IMCB · iShares Trust | 0,21% | 49.261 SH | 11 Eylül 2026 | Günlük |
| JQUA · J.P. Morgan Exchange-Traded Fund Tr… | 0,19% | 206.683 NS | 31 Temmuz 2026 | N-PORT |
| EUSA · iShares, Inc. | 0,19% | 50.884 SH | 11 Eylül 2026 | Günlük |
| RSP · Invesco Exchange-Traded Fund Trust | 0,19% | 2.662.408 SH | 02 Ekim 2026 | Günlük |
| LRND · New York Life Investments ETF Trust | 0,18% | 9.465 NS | 31 Temmuz 2026 | N-PORT |
| BSCU · Invesco Exchange-Traded Self-Indexe… | 0,18% | 5.589.000 | 02 Ekim 2026 | Günlük |
| DGRO · iShares Trust | 0,18% | 1.051.645 SH | 11 Eylül 2026 | Günlük |
| IMCG · iShares Trust | 0,18% | 97.153 SH | 11 Eylül 2026 | Günlük |
| SIZE · iShares Trust | 0,18% | 10.276 SH | 11 Eylül 2026 | Günlük |
| XOEF · iShares Trust | 0,17% | 526 SH | 11 Eylül 2026 | Günlük |
| BSCR · Invesco Exchange-Traded Self-Indexe… | 0,17% | 7.884.000 | 02 Ekim 2026 | Günlük |
| LCOW · Pacer Funds Trust | 0,16% | 529 NS | 31 Temmuz 2026 | N-PORT |
| CATH · Global X Funds | 0,15% | 25.943 NS | 31 Temmuz 2026 | N-PORT |
| ESGU · iShares Trust | 0,15% | 364.501 SH | 10 Eylül 2026 | Günlük |
| ESMV · iShares Trust | 0,15% | 158 SH | 10 Eylül 2026 | Günlük |
| GSY · Invesco Actively Managed Exchange-T… | 0,15% | 5.769.000 | 02 Ekim 2026 | Günlük |
| PALC · Pacer Funds Trust | 0,15% | 3.973 NS | 31 Temmuz 2026 | N-PORT |
| QUAL · iShares Trust | 0,14% | 888.569 SH | 11 Eylül 2026 | Günlük |
| PFIG · Invesco Exchange-Traded Fund Trust … | 0,13% | 175.000 | 02 Ekim 2026 | Günlük |
| VIG · VANGUARD SPECIALIZED FUNDS | 0,13% | 2.368.421 SH | 19 Ağustos 2026 | Günlük |
| VYM · VANGUARD WHITEHALL FUNDS | 0,13% | 1.680.027 SH | 19 Ağustos 2026 | Günlük |
| NUDV · Nushares ETF Trust | 0,13% | 834 NS | 31 Temmuz 2026 | N-PORT |
| USXF · iShares Trust | 0,12% | 24.978 SH | 11 Eylül 2026 | Günlük |
| ESG · FlexShares Trust | 0,12% | 2.010 NS | 31 Temmuz 2026 | N-PORT |
| JPUS · J.P. Morgan Exchange-Traded Fund Tr… | 0,12% | 6.837 NS | 31 Temmuz 2026 | N-PORT |
| PFM · Invesco Exchange-Traded Fund Trust | 0,11% | 11.940 SH | 02 Ekim 2026 | Günlük |
| IVE · iShares Trust | 0,10% | 695.597 SH | 11 Eylül 2026 | Günlük |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,10% | 14.085 SH | 02 Ekim 2026 | Günlük |
| IQSU · New York Life Investments ETF Trust | 0,10% | 4.253 NS | 31 Temmuz 2026 | N-PORT |
| VTV · VANGUARD INDEX FUNDS | 0,10% | 3.598.101 SH | 19 Ağustos 2026 | Günlük |
| VOOV · VANGUARD ADMIRAL FUNDS | 0,10% | 96.479 SH | 19 Ağustos 2026 | Günlük |
| CHRI · Global X Funds | 0,10% | 102 NS | 31 Temmuz 2026 | N-PORT |
| LGDX · Tidal Trust III | 0,10% | 1.814 NS | 31 Temmuz 2026 | N-PORT |
| IUSV · iShares Trust | 0,10% | 368.059 SH | 11 Eylül 2026 | Günlük |
| REVS · Columbia ETF Trust I | 0,09% | 3.986 NS | 31 Temmuz 2026 | N-PORT |
| SUSL · iShares Trust | 0,09% | 14.854 SH | 11 Eylül 2026 | Günlük |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,09% | 10.375 SH | 02 Ekim 2026 | Günlük |
| DSI · iShares Trust | 0,09% | 64.531 SH | 11 Eylül 2026 | Günlük |
| HAPI · Harbor ETF Trust | 0,08% | 5.320 NS | 31 Temmuz 2026 | N-PORT |
| AQLT · iShares Trust | 0,08% | 3.693 SH | 10 Eylül 2026 | Günlük |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0,08% | 55.415 SH | 02 Ekim 2026 | Günlük |
| WRND · New York Life Investments ETF Trust | 0,08% | 109 NS | 31 Temmuz 2026 | N-PORT |
| MPLY · Strategy Shares | 0,08% | 158 NS | 31 Temmuz 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,08% | 5.377 NS | 31 Temmuz 2026 | N-PORT |
| ESGG · FlexShares Trust | 0,07% | 1.064 NS | 31 Temmuz 2026 | N-PORT |
| EGLE · Global X Funds | 0,07% | 21 NS | 31 Temmuz 2026 | N-PORT |
| IWF · iShares Trust | 0,07% | 1.245.265 SH | 11 Eylül 2026 | Günlük |
| VONG · VANGUARD SCOTTSDALE FUNDS | 0,07% | 521.663 SH | 19 Ağustos 2026 | Günlük |
| IWS · iShares Trust | 0,06% | 135.157 SH | 11 Eylül 2026 | Günlük |
| PRF · Invesco Exchange-Traded Fund Trust | 0,06% | 85.655 SH | 02 Ekim 2026 | Günlük |
| CRBN · iShares Trust | 0,06% | 9.378 SH | 10 Eylül 2026 | Günlük |
| TOPC · iShares Trust | 0,06% | 258 SH | 11 Eylül 2026 | Günlük |
| ACVF · ETF Opportunities Trust | 0,06% | 1.125 NS | 31 Temmuz 2026 | N-PORT |
| USCL · iShares Trust | 0,06% | 22.073 SH | 10 Eylül 2026 | Günlük |
| HQGO · Lattice Strategies Trust | 0,06% | 354 NS | 31 Temmuz 2026 | N-PORT |
| XTR · Global X Funds | 0,05% | 34 NS | 31 Temmuz 2026 | N-PORT |
| XYLG · Global X Funds | 0,05% | 452 NS | 31 Temmuz 2026 | N-PORT |
| XRMI · Global X Funds | 0,05% | 344 NS | 31 Temmuz 2026 | N-PORT |
| XVV · iShares Trust | 0,05% | 4.833 SH | 10 Eylül 2026 | Günlük |
| XCLR · Global X Funds | 0,05% | 24 NS | 31 Temmuz 2026 | N-PORT |
| ILCV · iShares Trust | 0,05% | 9.460 SH | 11 Eylül 2026 | Günlük |
| PTLC · Pacer Funds Trust | 0,05% | 21.352 NS | 31 Temmuz 2026 | N-PORT |
| BBUS · J.P. Morgan Exchange-Traded Fund Tr… | 0,05% | 57.993 NS | 31 Temmuz 2026 | N-PORT |
| VOTE · TCW ETF Trust | 0,05% | 7.112 NS | 31 Temmuz 2026 | N-PORT |
| XYLD · Global X Funds | 0,05% | 21.020 NS | 31 Temmuz 2026 | N-PORT |
| VOO · VANGUARD INDEX FUNDS | 0,05% | 10.888.932 SH | 19 Ağustos 2026 | Günlük |
| ESGV · VANGUARD WORLD FUND | 0,05% | 95.134 SH | 19 Ağustos 2026 | Günlük |
| TOV · EA Series Trust | 0,05% | 1.758 NS | 31 Temmuz 2026 | N-PORT |
| BKLC · BNY Mellon ETF Trust | 0,05% | 34.718 NS | 31 Temmuz 2026 | N-PORT |
| VOXP · Advisors Series Trust | 0,05% | 36 NS | 31 Temmuz 2026 | N-PORT |
| IVV · iShares Trust | 0,05% | 5.283.923 SH | 11 Eylül 2026 | Günlük |
| ILCB · iShares Trust | 0,05% | 8.221 SH | 09 Eylül 2026 | Günlük |
| SPUU · Direxion Shares ETF Trust | 0,05% | 1.582 NS | 31 Temmuz 2026 | N-PORT |
| RWL · Invesco Exchange-Traded Fund Trust … | 0,05% | 64.661 SH | 02 Ekim 2026 | Günlük |
| QDPL · Pacer Funds Trust | 0,05% | 10.102 NS | 31 Temmuz 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,04% | 70.832 NS | 31 Temmuz 2026 | N-PORT |
| PBUS · Invesco Exchange-Traded Fund Trust … | 0,04% | 72.658 SH | 02 Ekim 2026 | Günlük |
| PBP · Invesco Exchange-Traded Fund Trust | 0,04% | 2.457 SH | 02 Ekim 2026 | Günlük |
| IYY · iShares Trust | 0,04% | 18.056 SH | 10 Eylül 2026 | Günlük |
| IWB · iShares Trust | 0,04% | 290.521 SH | 11 Eylül 2026 | Günlük |
| IWV · iShares Trust | 0,04% | 115.640 SH | 10 Eylül 2026 | Günlük |
| ITOT · iShares Trust | 0,04% | 544.118 SH | 11 Eylül 2026 | Günlük |
| QVML · Invesco Exchange-Traded Fund Trust … | 0,04% | 9.810 SH | 02 Ekim 2026 | Günlük |
| ILCG · iShares Trust | 0,04% | 17.162 SH | 11 Eylül 2026 | Günlük |
| VV · VANGUARD INDEX FUNDS | 0,04% | 440.643 SH | 19 Ağustos 2026 | Günlük |
| VTI · VANGUARD INDEX FUNDS | 0,04% | 11.984.400 SH | 19 Ağustos 2026 | Günlük |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0,04% | 69.366 SH | 19 Ağustos 2026 | Günlük |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,04% | 35.465 SH | 19 Ağustos 2026 | Günlük |
| HCMT · Direxion Shares ETF Trust | 0,04% | 2.917 NS | 31 Temmuz 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,04% | 17.007 NS | 31 Temmuz 2026 | N-PORT |
| SPXL · Direxion Shares ETF Trust | 0,04% | 32.772 NS | 31 Temmuz 2026 | N-PORT |
| TOK · iShares Trust | 0,04% | 1.209 SH | 11 Eylül 2026 | Günlük |
| PHDG · Invesco Actively Managed Exchange-T… | 0,04% | 325 SH | 02 Ekim 2026 | Günlük |
| URTH · iShares, Inc. | 0,03% | 37.976 SH | 10 Eylül 2026 | Günlük |
| DFSU · Dimensional ETF Trust | 0,03% | 9.950 NS | 31 Temmuz 2026 | N-PORT |
| ACWI · iShares Trust | 0,03% | 138.514 SH | 09 Eylül 2026 | Günlük |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,03% | 356.907 SH | 19 Ağustos 2026 | Günlük |
| TILT · FlexShares Trust | 0,03% | 8.216 NS | 31 Temmuz 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,03% | 69.465 NS | 31 Temmuz 2026 | N-PORT |
| ROUS · Lattice Strategies Trust | 0,02% | 2.228 NS | 31 Temmuz 2026 | N-PORT |
| NULV · Nushares ETF Trust | 0,02% | 5.737 NS | 31 Temmuz 2026 | N-PORT |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0,02% | 54.015 SH | 19 Ağustos 2026 | Günlük |
| IWD · iShares Trust | 0,02% | 198.738 SH | 11 Eylül 2026 | Günlük |
| QDEF · FlexShares Trust | 0,02% | 1.148 NS | 31 Temmuz 2026 | N-PORT |
| GTOS · Invesco Actively Managed Exchange-T… | 0,00% | 3.000 | 30 Eylül 2026 | Günlük |
| GTO · Invesco Actively Managed Exchange-T… | 0,00% | 66.000 | 02 Ekim 2026 | Günlük |
| DFAC · Dimensional ETF Trust | 0,00% | 6.792 NS | 31 Temmuz 2026 | N-PORT |
| BIV · VANGUARD BOND INDEX FUNDS | · | · | 15 Temmuz 2026 | Günlük |
| BLV · VANGUARD BOND INDEX FUNDS | · | · | 15 Temmuz 2026 | Günlük |
| BSV · VANGUARD BOND INDEX FUNDS | · | · | 15 Temmuz 2026 | Günlük |
| BND · VANGUARD BOND INDEX FUNDS | · | · | 15 Temmuz 2026 | Günlük |
| VCRB · VANGUARD MALVERN FUNDS | · | · | 15 Temmuz 2026 | Günlük |
| VPLS · VANGUARD MALVERN FUNDS | · | · | 15 Temmuz 2026 | Günlük |
| VCSH · VANGUARD SCOTTSDALE FUNDS | · | · | 15 Temmuz 2026 | Günlük |
| VCIT · VANGUARD SCOTTSDALE FUNDS | · | · | 15 Temmuz 2026 | Günlük |
| VCLT · VANGUARD SCOTTSDALE FUNDS | · | · | 15 Temmuz 2026 | Günlük |
| VTC · VANGUARD SCOTTSDALE FUNDS | · | · | 30 Temmuz 2026 | Günlük |
| BNDW · VANGUARD SCOTTSDALE FUNDS | · | · | 30 Temmuz 2026 | Günlük |
| VCEB · VANGUARD WORLD FUND | · | · | 30 Temmuz 2026 | Günlük |
ZTS Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
derecelendirme · 24 analist
AL
Medyan hedef
$89.50
+28,4%
4 16,7%
Güçlü Al
8 33,3%
Al
12 50,0%
Tut
0 0,0%
Sat
0 0,0%
Güçlü Sat
12 Aylık Fiyat Hedefi
14 analist · 2026-09-28Ortalama hedef $96.00 +37,8%
← Tüm hedeflerin altında
Mevcut fiyat $69.69
Düşük$80.00
Ortalama$96.00
Yüksek$155.00
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| ZTS | $53.46B | 20.9 | 2.3% | 28.2% | 66.0% | · |
| JNJ | · | 18.8 | 6.0% | 28.5% | 35.0% | 67.9% |
| MRK | · | 14.5 | 1.3% | 28.1% | 36.9% | · |
| PFE | · | 18.3 | -1.7% | 12.4% | 8.9% | · |
| BMY | · | 15.6 | -0.22% | 14.6% | 40.5% | · |
| RPRX | · | 21.7 | 5.1% | 32.4% | 8.0% | · |
| VTRS | · | -4.2 | -3.0% | -24.6% | -23.2% | 35.1% |
| CORT | $3.69B | 42.4 | 12.8% | 13.1% | 15.5% | · |
| ELAN | $11.25B | -48.1 | 6.2% | -4.9% | -3.5% | 55.0% |
| AXSM | $9.29B | -49.6 | 65.5% | -28.7% | -227.0% | · |
| LLY | · | 46.8 | 44.7% | 31.7% | 101.2% | · |
Son Haberler Bu şirketten bahseden son manşetler
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kaynak: SEC 10-Q dosyalandı Ağu 6, 2026